Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
about
Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatmentToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesStudy of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisToll-like receptor 9 in breast cancer.Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAbsent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinomaElevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patientsTumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinomaToll-like receptors as novel therapeutic targets for ovarian cancer.Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritisInterplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies.Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis.
P2860
Q26825259-5FB9A37C-C568-4D5F-9BF8-B010F91EB427Q26861234-94017DD2-DA8B-4428-ADE2-337C9D537D2EQ33762632-BFC34DDB-2D44-47D0-880A-7188F626A118Q33928402-4222A5E6-40E8-431B-90E6-86FA34B38EBAQ34698854-6F8B81CA-3694-4E0D-9B08-3E9B3A4D8DC5Q35241051-867F63A2-081F-46B7-839E-F847D62FC4C4Q35653787-1E63F7AD-C7F0-41F8-9A29-C4E37A9C31ABQ35798941-BE0868BC-7B9C-48D2-9325-CDA5559130D5Q35864309-B133C4A6-E34E-43BA-AC8E-5952EA22DE78Q37073220-11218155-4767-4868-AFA0-DA03D1168607Q37575463-C7E9E1D0-0308-4B84-AB0C-71BDBD136041Q37605221-2F2EA546-9230-4D56-8377-2F2257E00E20Q37952071-C532474D-4EA6-4B34-A98A-5336482621D0Q38039958-7554B1E6-0BB2-4368-BE7D-61AB7A6F1920Q38103581-A139357B-0121-4D6C-833A-0E1019175E8AQ38410178-A7A12E03-7206-41AB-82F7-AB42E0AAF838Q38720388-2A25D728-3E8A-4F2C-924E-B0C5CCB19BDEQ38727874-E33CFE3D-3719-4EEA-8795-DF8E3FC80A99Q39115582-D59D733A-01C3-4FBB-8CF6-2F7F51844B0FQ39305431-1173CA3C-BD68-44C0-8C2E-EB9116321F8DQ40220618-70BD9035-482B-463C-AF8F-80B1D5FC9E48Q40893702-A30923F1-9D20-4913-9770-4A586293ADFAQ41497232-5BF17176-FFFB-4E41-BB69-BDB0C17C73B7Q52726017-58DE3542-922C-41C8-B00A-70C4AC2520F2
P2860
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@ast
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@en
type
label
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@ast
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@en
prefLabel
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@ast
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@en
P2093
P2860
P50
P1433
P1476
Toll-like receptor 9 expressio ...... h poorly differentiated tumors
@en
P2093
Allison Jones
Cornelia Hauser-Kronberger
Daniel Egle
Daniel Reimer
Elisabeth Müller-Holzner
Georg Goebel
Petra Obexer
Regina Berger
Roland Reitsamer
Wolfgang Doppler
P2860
P304
P356
10.1111/J.1349-7006.2010.01491.X
P577
2010-01-12T00:00:00Z